In contrast to a previous report showing that axillary node involvement was more frequent in BRCA2 carriers (7), in our study BRCA2 mutations were more frequently found in patients without lymph node metastasis (Table 2). Here, BRCA2 is linked to metastatic malignant neoplasm in the lymph nodes.